1. Mumps (parotitis).ppt

Mumps (Parotitis)

1. MUMPS ( PAROTITIS )
Ratheesh.R
SLMGNC

2. Mumps (parotitis)
Inflammation of the salivary glands.
Mainly the parotid glands are affected.
There are three pairs of salivary glands.
Two parotid glands, the largest, one in each cheek, over the
angle of the jaw , in front of the ear.
Two sub mandibular glands at the back of the mouth.
Two sub-lingual glands, under the floor of the mouth.

3. Salivary glands .

4. Definition
Inflammation of the parotid gland

5. Viral etiology
Caused by mumps virus.
Family: paramyxoviridae.
Genus: parainfluenza virus.
The viral genome is ss-RNA, with negative polarity.
The fusion protein enables the virus to form
multinucleated giant cell by fusing infected cells together

6. Transmission
By inhalation of respiratory droplets, during sneezing and
coughing.
The virus sheds in saliva.
Also, the virus can be transmitted by direct contact with
saliva.

7. Phathophysiology
Due to etiological factor
Respiratory transmission of virus
Replication in nasopharynx and regional lymph nodes
Viremia 12-25 days after exposure with spread to tissues
Multiple tissues infected during viremia
Mumps or Parotitis

8. Clinical features
Mumps is a highly infectious child-hood disease.
IP, 14 to 18 days.
Mumps starts with moderate fever, malaise, pain on
chewing or swallowing, particularly acidic liquids.
Followed by inflammation of the salivary glands,
particularly the parotid glands.
The swelling appears in front of the ear.

9. Parotitis .

10. Parotitis .

11. Complications
Aseptic meningitis.
Encephalitis.
Orchitis, after puberty. Inflammation of one or both
testicles. Usually unilateral , rarely leads to sterility .
Pancreatitis.
Oophoritis.
Thyroiditis.
Deafness
Death

12. Prognosis & lab diagnosis
In the absence of complications recovery is usual.
Lab. Diagnosis, by detection of IgM antibody to mumps
virus.
Serologic testing
By detection of IgM antibody to mumps virus.
Significant increase in IgG antibody between acute and
convalescent specimens

13. Prevention
A live attenuated vaccine is available (MMR).
It contains mumps, measles and rubella attenuated
virus strains.
Administered in one dose, intramuscularly or
subcutaneously.
The vaccine is protective.

14. Mumps Vaccine Information
Composition Live virus (Jeryl Lynn strain)
Efficacy 95% (Range, 90%-97%)
Duration of
Immunity Lifelong
Schedule 1 Dose
Should be administered with measles and rubella
(MMR)

15. Treatment
There is no specific anti-viral drug therapy.
Treatment is supportive by treating symptoms, using
antipyretics and analgesics.

16. Nursing Management
The child must rest in bed until the fever goes away.
Isolate the child, to prevent spreading the disease to
other.
Use analgesics and anti-pyretic to ease symptoms.
Avoid food that require chewing.
Avoid sour foods that stimulate saliva production.
Drink plenty of water.
Use cold compress to ease the pain of swelling
glands.